Schedule 13G ownership disclosure

GALERA THERAPEUTICS INC

Security class unavailable · CUSIP: 36338D108

Event date: 2024-03-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0560%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001376474-24-000167
Form type
SC 13G
Filer
ALPHA PHARMA Investments LLC
CIK
CIK 2018003
Filed
Apr 16, 2024
Reporting period
Mar 22, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub